Ashland (NYSE: ASH) has provided guidance for fiscal 2026, projecting sales between $1.835 billion and $1.87 billion with adjusted EBITDA expected to range from $385 million to $400 million.
The specialty chemicals company disclosed during its second quarter fiscal 2026 earnings call that timing issues related to its Hopewell facility operations will result in reduced savings of $10 million to $12 million compared to previous expectations.
Earnings Call Details
The guidance update was delivered during Ashland's Q2 FY2026 earnings call, where the company addressed the Hopewell facility ramp-up challenges and their impact on projected cost savings. The earnings call also covered pricing actions and demand trends affecting the company's operations.
About Ashland
Ashland is a global specialty chemicals company that serves customers in various industries including personal care, pharmaceuticals, and industrial applications. The company trades on the New York Stock Exchange under the ticker symbol ASH.
The Hopewell facility represents part of Ashland's operational infrastructure, and the timing delays in its ramp-up have necessitated adjustments to the company's financial projections for the current fiscal year.
